HYPERTROPHIC ANAL PAPILLA

This adverse event was reported 24 times

These drugs are most commonly taken by patients reporting HYPERTROPHIC ANAL PAPILLA:

# Drug Count
0 ISOTRETINOIN 5
1 ALENDRONATE SODIUM 4
2 ADALIMUMAB 3
3 AMLODIPINE 2
4 AMLODIPINE BESYLATE 2
5 ATORVASTATIN CALCIUM 2
6 BASILIXIMAB 2
7 CALCIUM 2
8 CLOPIDOGREL 2
9 CONJUGATED ESTROGENS 2
See all common drugs associated with HYPERTROPHIC ANAL PAPILLA

HYPERTROPHIC ANAL PAPILLA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAZAROTENE 1 0.0008
1 BISMUTH SUBSALICYLATE 1 0.0002
2 BASILIXIMAB 2 0.0002
3 ATOGEPANT 1 0.0001
4 OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE 1 0.0001
5 ISOTRETINOIN 5 0.0001
6 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 2 0.0001
7 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 1 0.0001
8 ERGOCALCIFEROL 2 0.0001
9 LEVOCETIRIZINE DIHYDROCHLORIDE 1 0.0000
See all drugs enriched for association with HYPERTROPHIC ANAL PAPILLA

HYPERTROPHIC ANAL PAPILLA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 1 0.0002
1 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1 0.0001
2 Retinoid [EPC] 5 0.0000
3 Calcium [EPC] 2 0.0000
4 Estrogen [EPC] 2 0.0000
5 Thiazide Diuretic [EPC] 2 0.0000
6 Aromatase Inhibitor [EPC] 1 0.0000
7 Proteasome Inhibitor [EPC] 1 0.0000
8 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
9 Fluoroquinolone Antibacterial [EPC] 1 0.0000
See all drug classes enriched for association with HYPERTROPHIC ANAL PAPILLA